SCHEMBL6907341

SCHEMBL6907341

CCN(C#N)c1ncccc1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNMA1 Q12791 1/20 0.35
CYP11B2 P19099 1/20 0.33
OPRM1 P35372 2/20 0.32
SIGMAR1 Q99720 1/20 0.32
LMNA P02545 4/20 0.31
HTT P42858 3/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2D6 P10635 2/20 0.31
CYP2C9 P11712 2/20 0.31
CYP2C19 P33261 2/20 0.31
HPGD P15428 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.30
ALDH1A1 P00352 2/20 0.30
MEN1 O00255 1/20 0.30
NPC1 O15118 1/20 0.30
MAPT P10636 1/20 0.30
MAPK1 P28482 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5534796 0.74 ALDH1A1 (0.40) KCNMA1LMNAHTTSMN1; SMN2L3MBTL1
SCHEMBL30749067 0.70 CYP2D6 (0.44) KCNMA1OPRM1LMNAHTTSMN1; SMN2
SCHEMBL18186740 0.70 OPRM1 (0.46) OPRM1SIGMAR1LMNAHTTL3MBTL1
SCHEMBL28184771 0.68 MAPT (0.32) HTTMAPTKDM4E
SCHEMBL29058366 0.68 NAPRT (0.38) LMNAHTTSMN1; SMN2CYP3A4CYP2D6
SCHEMBL31419074 0.67 GAA (0.37) OPRM1HTTL3MBTL1ALDH1A1NPC1
SCHEMBL30748986 0.67 CHRM5 (0.43) SMN1; SMN2ALDH1A1MAPTNPSR1
SCHEMBL11510699 0.67 ALDH1A1 (0.36) CYP3A4L3MBTL1ALDH1A1MEN1NPC1
SCHEMBL10049954 0.66 NAPRT (0.41) OPRM1HTTL3MBTL1ALDH1A1NPC1
SCHEMBL2243707 0.66 NPSR1 (0.44) OPRM1LMNAHTTSMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040116418-A1 Compounds and methods for inhibition of HIV and related viruses MEDIVIR AB (SE) 2004-06-17 US disclosed
US-6376492-B1 GUANIDINE DERIVATIVES MEDIVIR AB (SE) 2002-04-23 US disclosed
US-5849769-A N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection MEDIVIR AB (SE) 1998-12-15 US disclosed
EP-0706514-B1 COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES MEDIVIR AB (SE) 1998-11-18 EP disclosed
EP-0706514-A1 COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES MEDIVIR AB (SE) 1996-04-17 EP disclosed
WO-1995006034-A1 COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES MEDIVIR AB (SE) 1995-03-02 WO disclosed